SAB Biotherapeutics

SAB Biotherapeutics

More money is flowing to a South Dakota company that hopes to create a treatment for COVID-19.

SAB Biotherapeutics in Sioux Falls is getting $57.5 million from agencies involved in Operation Warp Speed. That’s the government’s effort to find and fund treatments for the disease.

In The Moment ... August 21, 2020 Show 886 Hour 1

SAB Biotherapeutics in Sioux Falls announced the first step in its trial of a COVID 19 therapeutic earlier this month, dosing the first group of healthy volunteers. Today, they're announcing the trial's next step.

Science and Technology reporting is brought to you by SDN Communications, your business broadband provider. Learn more at

Eddie Sullivan

Apr 10, 2020

In The Moment ... April 10, 2020 Show 793 Hour 2

The human body has its own, powerful immune response that fights off illness and disease. Scientists at SAB Biotherapeutics in South Dakota are working to harness nature and save lives in the fight against coronavirus. They've been doing this work for decades and were uniquely positioned to respond rapidly to the novel coronavirus outbreak.  Joining us for an update on the development of therapeutics, we welcome Eddie Sullivan, president & CEO of SAB Biotherapeutics. 

Adria Botella


A South Dakota company is working on a therapeutic to treat COVID 19 – the disease caused by the coronavirus. S-A-B Biotherapeutics has been working on other coronavirus strains and has had safety trials already conducted.  C-E-O Eddie Sullivan says they are using what they have learned to quickly advance therapeutics for COVID 19.



Working On A COVID-19 Therapeutic

Mar 11, 2020

In The Moment ... March 10, 2020 Show 770 Hour 1

SDPB is bringing you the latest information on the coronavirus and COVID-19, including research into the nature of human disease.  Eddie Sullivan, Ph.D. is president and CEO of South Dakota's SAb Biotherapeutics and joins In the Moment to discuss the complexity of finding a solution. 

Education and Healthcare reporting on SDPB is supported by Monument Health of Rapid City

Adria Botella

Blaine Crissman is with South Dakota Equity Partners and Eddie Sullivan is with SAB Biotherapeutics. SAB Biotherapeutics is a clinical-stage biopharmaceutical company developing human immunotherapies. SDEP is investing $1 million dollars in SAB. This is the first investment made by the new private equity fund focusing on South Dakota growth-stage companies.

Advancements Towards A Treatment For Ebola

Aug 24, 2018
Adria Botella

Eddie Sulivan, SAB Biotherapeutics president and CEO, joined Innovation to discuss the recent advancements made by his company.

SAB Biotherapeutics announced its anti-Ebola immunotherapy provided 100% protection against a lethal dose of the Ebola virus in a recent animal study published in The Journal of Infectious Diseases.

The Ebola virus disease is a severe, often fatal illness in humans. There is currently no licensed treatment proven to neutralize the virus. 

Lori Walsh

In The Moment ... June 8, 2018 Show 354 Hour 2

The USD Discovery District has its first anchor tenant - SAB Biotherapeutics, Inc.  SAB president, CEO and co-founder Eddie Sullivan talks about being the first tenant and shares his goals for the first project.  He's joined by Rich Naser, president of the USD Discovery District.

Melissa Ullerich

Ag Innovation is the focus of a panel conversation during the Governor’s Ag Summit in Aberdeen. Other topics include animal health, economics and succession planning.  The annual event brings awareness to the economic potential of agriculture in South Dakota.

Jerry Pommer is the Chief Compliance Officer of SAb Biotherapeutics.  He says the company's research project, DiversitAb, uses genetically-designed cattle to produce human antibodies against global diseases.

SAB Biotherapeutics, Inc.

Eddie Sullivan is the President, CEO and Co-Founder of SAB Biotherapeutics, Inc. based in Sioux Falls. The biopharmaceutical company leads the science and manufacturing of polyclonal antibody therapies. Eddie Sullivan has been named chair of the food and agriculture section governing board for the Biotechnology Innovation Organization or Bio. It’s the industry’s largest international trade association.